IRIS Regtech Solutions

Q3 FY22 Earnings Call Analysis

IT - Software

Full Stock Analysis
fundraise: Yescapex: No informationrevenue: Category 3margin: Category 3orderbook: No information
💰

fundraise

Any current/future new fundraising through debt or equity?

- The company is on the borderline regarding a rights issue, which was initially aimed at managing attrition and investing in growth. - Promoters currently do not have the funds to subscribe to the rights issue; hence, the rights issue remains in a state of uncertainty. - There is a perception risk if promoters do not participate in the rights issue, but the company maintains integrity and transparency about the situation. - No concrete decision has been made yet; the company is in a "quandary" but is "bordering on tilting towards" not proceeding with the rights issue. - There is no mention of new debt fundraising in the transcript. - The company continues to focus on organic growth and managing cash flows prudently, including hiring senior resources despite cash constraints, signaling confidence in future growth.
🏗️

capex

Any current/future capex/capital investment/strategic investment?

- No explicit mention of current or future capital expenditure (capex) or strategic investments detailed in the transcript. - The company emphasizes cautious capital use, noting that some growth initiatives (e.g., US government reporting, ESG in Europe) can happen "without too much capital" as they "muddle along." - Discussion on rights issue highlights promoter constraints in subscribing due to lack of capital; no final decision yet on proceeding. - The company has hired senior personnel at high cost, indicating investment in talent as a strategic move signaling confidence in growth. - Focus is more on organic growth through technology innovation, new product launches (e.g., IRIS Litigation Management System, disclosure management platform), and developing markets rather than large capex or acquisitions. - No mention of imminent large-scale investments or capital-intensive projects; emphasis is placed on scalability of existing platforms and gradual market expansion.
📊

revenue

Future growth expectations in sales/revenue/volumes?

- Growth is expected to be driven by new mandates such as ESG reporting, particularly in markets like Europe and the US government reporting domain. - The Create segment showed robust growth of 46%, with good profitability and scale economics improving margins. - The Collect segment growth has been stagnant but potential exists as regulatory mandates roll out. - Expansion into replacement markets by targeting customers using inefficient or pricier solutions. - Introduction of new products like the Disclosure Management platform and Litigation Management System to tap adjacent markets. - Early adoption by customers and ongoing feedback loops expected to stabilize and ramp offerings within a year. - Continued focus on winning government tenders and scaling regulated markets as mandates unfold gradually. - Management remains optimistic about a gradual ramp-up in regulatory-driven demand and replacement market opportunities. - Investment in senior resources and technology platforms shows confidence in future growth potential.
📈

margin

Future growth expectations in earnings/operating earnings/profits/EPS?

- IRIS sees growth opportunities primarily from new mandates like US government reporting and ESG initiatives in Europe starting next year. - Create segment showed robust 46% growth with improving profitability due to scale economies and increased platform usage. - Collect segment revenue growth is slower, affected by regulator delays, but expected to improve with new tenders expected by December. - ESG filings under SEBI are increasing, indicating a ramp-up in XBRL adoption and potential growth. - The company is investing in senior hires and marketing to drive growth, signaling confidence despite current cautious cash flow. - Attrition, especially at senior level, remains a key challenge affecting growth and operational efficiency. - Management cautions that growth is linked to regulatory timelines which are uncertain, with some mandates only expected to materialize next fiscal year. - Overall, the outlook is cautiously optimistic with targeted initiatives and new product launches expected to drive earnings and profitability expansion.
📋

orderbook

Current/ Expected Orderbook/ Pending Orders?

- The company is currently bidding on four projects, but specific timelines for decisions are unknown. - There is no clear clarity on the budget cycles of these projects, making it difficult to predict when orders will materialize. - Some tenders and RFP screening by regulators have started, but actual scaling and implementations are awaited. - The company has not lost any existing orders but has not won new significant orders recently; the situation is described as being "Trishanku is still hanging in the sky." - Delays in some regulatory mandates and implementations, such as the iFile project and GST-related systems, affect order inflow timing. - Optimism exists that some of these orders or mandates may come through by December, but definite timelines remain uncertain. - Integration and testing phases for some offerings, such as e-invoice IRP system, are ongoing with expected go-live in early December.